Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ninan

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
Archives of General Psychiatry|May 1, 1997
Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatmentN R Schooler, S J Keith, J B Severe, et al.
Biological Psychiatry|February 2, 2002
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combinationRobert M A Hirschfeld, David L Dunner, Gabor Keitner, et al.
Archives of General Psychiatry|May 4, 2005
Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is notAlan F Schatzberg, A John Rush, Bruce A Arnow, et al.
The Journal of Clinical Psychiatry|February 5, 2009
The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studiesAlan J Gelenberg, Michael E Thase, Roger E Meyer, et al.
Biological Psychiatry|September 11, 2007
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phasesMartin B Keller, Madhukar H Trivedi, Michael E Thase, et al.
The Journal of Clinical Psychiatry|August 10, 2007
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT StudyJames H Kocsis, Michael E Thase, Madhukar H Trivedi, et al.
The Journal of Clinical Psychiatry|September 15, 2007
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phasesMartin B Keller, Madhukar H Trivedi, Michael E Thase, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
Archives of General Psychiatry|May 1, 1997
Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatmentN R Schooler, S J Keith, J B Severe, et al.
Biological Psychiatry|February 2, 2002
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combinationRobert M A Hirschfeld, David L Dunner, Gabor Keitner, et al.
Archives of General Psychiatry|May 4, 2005
Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is notAlan F Schatzberg, A John Rush, Bruce A Arnow, et al.
The Journal of Clinical Psychiatry|February 5, 2009
The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studiesAlan J Gelenberg, Michael E Thase, Roger E Meyer, et al.
Biological Psychiatry|September 11, 2007
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phasesMartin B Keller, Madhukar H Trivedi, Michael E Thase, et al.
The Journal of Clinical Psychiatry|August 10, 2007
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT StudyJames H Kocsis, Michael E Thase, Madhukar H Trivedi, et al.
The Journal of Clinical Psychiatry|September 15, 2007
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phasesMartin B Keller, Madhukar H Trivedi, Michael E Thase, et al.
Pageof 12